agilon health (NYSE:AGL) Trading Up 11.8% – Time to Buy?

agilon health, inc. (NYSE:AGL) rose 11.8% during mid-day trading on Monday . The stock traded as high as $2.47 and last traded at $2.42. Approximately 1,276,177 shares were traded during trading, a decline of 74% from the average daily volume of 4,969,932 shares. The stock had previously closed at $2.16.

Analyst Upgrades and Downgrades

AGL has been the topic of a number of recent analyst reports. Barclays upped their price objective on agilon health from $2.00 to $3.00 and gave the stock an “underweight” rating in a report on Thursday, May 8th. TD Cowen raised their price objective on agilon health from $3.50 to $6.00 and gave the stock a “hold” rating in a report on Tuesday, April 15th. JMP Securities reaffirmed a “market perform” rating on shares of agilon health in a research report on Monday, April 28th. Royal Bank of Canada raised their price objective on agilon health from $3.00 to $3.50 and gave the stock an “outperform” rating in a report on Wednesday, February 26th. Finally, Citigroup upgraded shares of agilon health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $3.25 to $5.00 in a report on Friday, April 25th. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, agilon health presently has a consensus rating of “Hold” and an average target price of $4.79.

agilon health Trading Up 0.2%

The business’s 50 day moving average price is $3.50 and its 200-day moving average price is $3.21. The firm has a market cap of $945.88 million, a price-to-earnings ratio of -2.43 and a beta of 0.14. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the business earned ($0.02) EPS. The business’s quarterly revenue was down 4.5% on a year-over-year basis. Equities analysts expect that agilon health, inc. will post -0.59 EPS for the current year.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently modified their holdings of AGL. Ieq Capital LLC bought a new stake in shares of agilon health during the 4th quarter valued at about $26,000. Signaturefd LLC grew its holdings in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock valued at $27,000 after purchasing an additional 8,467 shares during the last quarter. Humankind Investments LLC acquired a new stake in shares of agilon health during the 4th quarter worth approximately $30,000. Raymond James Financial Inc. acquired a new stake in shares of agilon health during the 4th quarter worth approximately $33,000. Finally, Cerity Partners LLC bought a new stake in shares of agilon health in the 4th quarter worth approximately $34,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.